We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+25.64%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.2B
AUM Growth
+$61.2M
Cap. Flow
-$100M
Cap. Flow %
-8.35%
Top 10 Hldgs %
47.68%
Holding
49
New
5
Increased
14
Reduced
19
Closed
11

Top Buys

Rank Stock Value
1
DYN icon
Dyne Therapeutics
DYN
+$34.8M
2
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$27.8M
3
RGEN icon
Repligen
RGEN
+$23.8M
4
EVH icon
Evolent Health
EVH
+$22M
5
KYMR icon
Kymera Therapeutics
KYMR
+$17.9M

Top Sells

Rank Stock Value
1
ATEC icon
Alphatec Holdings
ATEC
+$39.8M
2
LIVN icon
LivaNova
LIVN
+$38.9M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$31M
4
NTRA icon
Natera
NTRA
+$21.1M
5
TCMD icon
Tactile Systems Technology
TCMD
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$95M 7.9%
5,940,132
+1,159,572
+24% +$14.2M
FNA
2
DELISTED
Paragon 28, Inc.
FNA
$67.8M 5.64%
10,154,643
+1,979,811
+24% +$15M
EVH icon
3
Evolent Health
EVH
$348M
$65M 5.41%
2,298,261
+852,956
+59% +$22M
AXGN icon
4
Axogen
AXGN
$2.27B
$57.3M 4.77%
4,090,296
+746,263
+22% +$8.25M
ATRC icon
5
AtriCure
ATRC
$1.92B
$52.3M 4.35%
1,865,536
-99,167
-5% -$2.44M
INSM icon
6
Insmed
INSM
$21.4B
$50.3M 4.18%
688,910
+137,607
+25% +$10.2M
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$8.84B
$48.2M 4.01%
943,611
-256,897
-21% -$13.2M
XENE icon
8
Xenon Pharmaceuticals
XENE
$6.06B
$46.5M 3.87%
1,181,662
-124,598
-10% -$5.02M
NEO icon
9
NeoGenomics
NEO
$1.96B
$45.4M 3.78%
3,076,555
-706,006
-19% -$11M
DYN icon
10
Dyne Therapeutics
DYN
$4.7B
$45.2M 3.76%
1,257,285
+874,852
+229% +$34.8M
TNDM icon
11
Tandem Diabetes Care
TNDM
$1.34B
$43.5M 3.62%
1,025,307
+316,825
+45% +$13.4M
RARE icon
12
Ultragenyx Pharmaceutical
RARE
$2.45B
$41.9M 3.49%
755,102
-208,044
-22% -$10.6M
PHLT
13
DELISTED
Performant Healthcare Inc
PHLT
$41.9M 3.49%
11,210,400
+696,200
+7% +$2.38M
TMDX icon
14
Transmedics
TMDX
$2.64B
$41.7M 3.47%
265,734
-34,866
-12% -$5.37M
OSCR icon
15
Oscar Health
OSCR
$9.41B
$37.5M 3.12%
1,765,892
-100,030
-5% -$1.8M
PODD icon
16
Insulet
PODD
$11.5B
$37M 3.08%
159,082
-56,555
-26% -$11.6M
HCAT icon
17
Health Catalyst
HCAT
$154M
$35M 2.91%
4,296,490
+340,401
+9% +$2.46M
ANAB icon
18
AnaptysBio
ANAB
$1.58B
$31.8M 2.64%
948,131
+168,973
+22% +$5.77M
CDMO
19
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$31.5M 2.62%
+2,771,853
New +$27.8M
VERA icon
20
Vera Therapeutics
VERA
$2.3B
$31.2M 2.59%
705,234
-300,489
-30% -$11.4M
PLRX icon
21
Pliant Therapeutics
PLRX
$64.4M
$28.9M 2.4%
2,575,546
-825,667
-24% -$10.3M
RGEN icon
22
Repligen
RGEN
$7.96B
$24.7M 2.05%
+165,873
New +$23.8M
NTRA icon
23
Natera
NTRA
$38.3B
$23.5M 1.95%
184,939
-184,129
-50% -$21.1M
GPCR icon
24
Structure Therapeutics
GPCR
$3.41B
$22.2M 1.85%
506,222
-84,425
-14% -$3.26M
BCYC
25
Bicycle Therapeutics
BCYC
$269M
$21.9M 1.82%
967,006
-417,762
-30% -$9.64M
1
2

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, First Light Asset Management held 49 positions worth $1.2B, up 5.4% from $1.14B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

First Light Asset Management withdrew a net $100M in Q3 2024, closing 11 positions and reducing 19 holdings. Its most notable exit was LivaNova, an estimated $38.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier, followed by Industrials.

Against the trend, First Light Asset Management opened a new position in Avid Bioservices, Inc. Common Stock worth $31.5M.

  • First Light Asset Management's largest Q3 2024 buy was Avid Bioservices, Inc. Common Stock: 2,771,853 shares worth $31.5M.
  • First Light Asset Management added most to Dyne Therapeutics in Q3 2024, an estimated $34.8M increase.
  • First Light Asset Management's biggest Q3 2024 reduction was Alphatec Holdings, cutting an estimated $39.8M.
  • First Light Asset Management fully exited LivaNova in Q3 2024, selling an estimated $38.9M.
  • First Light Asset Management's ten largest holdings make up 48% of its $1.2B portfolio in Q3 2024.
  • First Light Asset Management opened 5 new positions and closed 11 in Q3 2024.
  • First Light Asset Management's portfolio value rose 5.4% quarter-over-quarter to $1.2B.

Based on First Light Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.